अमूर्त

Teens and millennials with hyperglycaemia and the implications of tracking on glycaemic control.

Marco Marigliano

Adolescents and young adults with type 1 diabetes had the lowest glycemic control of any age group with type 1 diabetes. Although continuous glucose monitoring (CGM) has been shown to improve glycemic control in adults, its benefit in adolescents and young adults has not been demonstrated Randomized clinical trial conducted Between January 2018 and May 2019, 14 endocrinology practises in the United States recruited 153 people aged 14 to 24 with type 1 diabetes and screening haemoglobin A1c (HbA1c) levels ranging from 7.5% to 10.9%. HbA1c change from baseline to 26 weeks was the primary endpoint. There were 20 secondary outcomes, which included additional HbA1c outcomes, CGM glucose measures, and patient-reported outcomes with multiple comparisons adjusted.